Decline depth
-39.7%
From rolling 252-day high of $12.43, 146d ago.
Past the 30% Amber threshold.
-39.7%
from rolling 252-day high of $12.43 set 2026-02-25 · 146d ago
Current
$7.83
Decline depth
-39.7%
Decline σ
4.8σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$IBRX landed on the list 2026-03-25, down 35.1% from its 52-week high that day — now down -39.7%.
Roughly where it joined — no recovery, no further break. It bottomed 46.4% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-25 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
IBRX qualifies for the Amber List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.8σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.48% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about IBRX.
IBRX qualifies for the Amber List on decline depth — down -39.7% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 4.8σ over 20 bars.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 1 (red), weekly 1 (red), monthly 2U (red).
Earnings on file: 2026-02-23. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $1.83
56.6% of range
52W high $12.43
Sector context · Healthcare
148 other Healthcare tickers are on Broken Stocks.
70
Red List
39
Amber
39
Watch
-34.5%
Median decline
Worst in sector: KRRO (-79.4%). Least-bad: ATR (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to IBRX
Red List
ARDX
Ardelyx, Inc.
Red List
CRSP
CRISPR Therapeutics AG
Amber ListRecovering
SPOK
Spok Holdings, Inc.
Amber List
TNDM
Tandem Diabetes Care, Inc.
Amber List
UHS
Universal Health Services, Inc.
Red List
OPCH
Option Care Health, Inc.
Questions about IBRX
What people ask.
Why is IBRX on Broken Stocks?
IBRX qualifies for the Amber List on decline depth. It is down -39.7% from its rolling 252-day high of $12.43, set on 2026-02-25 — 146d ago.
Is IBRX a falling knife?
Not by the strict technical definition. IBRX is down -39.7% from its 52-week high, but that high was set 146d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. IBRX is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is IBRX a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is IBRX trading inside its 52-week range?
At $7.83, IBRX sits 56.6% of the way from its 52-week low ($1.83) to its 52-week high ($12.43). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has IBRX been declining?
The current 39.7% decline accrued over 146d, which annualizes to roughly -99.3% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does IBRX compare to its sector?
There are 148 other Healthcare tickers on Broken Stocks: 70 Red, 39 Amber, 39 Watch, with 25 showing recovering structural signals. Median sector decline is -34.5% — IBRX's decline is deeper than the sector median.
Does IBRX's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-23) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.